Physician profile
Joel E Chasan
NPI 1730522830
$1,137.18
in general payments reported to CMS, 2019-2025
7 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $76.02 · 2021: $296 · 2022: $83.44 · 2023: $147 · 2024: $79.00 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $558.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $369.65 | 2020-2025 | Eylea, Eylea Hd |
| Alimera Sciences, INC. | $225.55 | 2023-2024 | Iluvien, Yutiq |
| Allergan, INC. | $173.05 | 2021 | |
| Novartis Pharmaceuticals Corporation | $123.64 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $122.91 | 2021 | |
| Regeneron Pharmaceuticals, INC. | $83.44 | 2022 | |
| Abbvie INC. | $38.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Chasan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.